News

VCI Global's Bold Move into AI with Marvis Investment

VCI Global's Bold Move into AI with Marvis Investment

VCI Global's Strategic Investment in AI Innovation

In a significant move towards expanding its artificial intelligence (AI) portfolio, VCI Global Limited (NASDAQ: VCIG) has invested in Marvis Inc., an innovative AI startup revolutionizing digital clone technology. This investment marks a pivotal step for the company, demonstrating its commitment to fostering advancements in emerging technologies.

What is Marvis?

Marvis, a Delaware corporation, specializes in developing advanced AI agents designed to automate and replicate routine tasks. Founded by Masaaki Hatano, a seasoned entrepreneur with a successful history in the tech industry, Marvis is set to reshape the future of work. Hatano’s prior success with DFA Robotics KK, which sold for over JPY 3.5 billion, reinforces the potential of Marvis and its technology.

Advanced Technology at Work

The AI agents created by Marvis leverage proprietary models to handle repetitive tasks, enabling users to focus on strategic initiatives. This shift not only enhances productivity but also encourages innovative thinking within organizations. With the increasing demand for streamlined operations, Marvis' introduction of affordable AI alternatives to traditional Robotic Process Automation (RPA) represents a significant breakthrough in the sector.

Future Plans and Goals

Looking towards the future, Marvis plans to operate fully by November 2024 and aims to list on NASDAQ by 2028, targeting a market capitalization of US$20 billion. Currently in its seed funding phase, Marvis is raising up to US$5 million, attracting interest from prominent advisors such as Google, Intel, and IBM. Their backing not only underscores the viability of Marvis’ vision but also enhances its credibility within the AI community.

The Growing AI Market

According to market research, the global AI agents market is projected to exceed US$55 billion by 2030, with an impressive compound annual growth rate (CAGR) of approximately 45% from 2024 to 2030. This rapid growth trajectory is fueled by the escalating need for automation and advancements in Natural Language Processing (NLP). Marvis is strategically positioned to be at the forefront of this evolution in the technology landscape.

Partnerships Fueling Success

Marvis is not only focusing on tech development; strategic partnerships have been established with industry giants like Toshiba Tec Malaysia, Hitachi Global, and NTT Data Group. These alliances are crucial for large-scale implementation and adoption of its AI technology, ensuring that Marvis can leverage existing infrastructures while expanding its reach.

Commitment to Innovation

“This is just the beginning for Marvis; the AI agents are set to transform the world. By 2028, we aim to empower humanity by alleviating both digital and physical tasks,” stated Masaaki Hatano, Co-CEO of Marvis, shedding light on the visionary approach the company is undertaking.

VCI Global’s Vision

Dato’ Victor Hoo, Group Executive Chairman and CEO of VCI Global, emphasized the significance of this investment in positioning the company at the forefront of transformative technology. He noted, “We recognize 2025 as the year of AI agents and are committed to investing in innovative startups.” This approach not only enhances VCI Global's portfolio but also strengthens its leadership in the rapidly evolving tech landscape.

About VCI Global Limited

VCI Global is a diversified holding company based in Kuala Lumpur, Malaysia, operating across multiple sectors including Capital Market Consultancy, Fintech, Real Estate, AI & Robotics, Renewable Energy, and Cybersecurity. Each business segment is dedicated to delivering innovative solutions and exceptional value. The company is committed to fostering growth and transformation on a global scale, establishing a strong presence in critical markets including Asia-Pacific, Europe, and the Middle East.

Frequently Asked Questions

What is the significance of VCI Global's investment in Marvis?

This investment highlights VCI Global's commitment to expanding its AI portfolio and fostering innovation within emerging technologies.

Who founded Marvis?

Marvis was founded by Masaaki Hatano, a serial entrepreneur with a successful track record in technology.

What market growth is anticipated for AI agents?

The global AI agents market is projected to exceed US$55 billion by 2030, with a growth rate of approximately 45% per year.

What types of partnerships does Marvis have?

Marvis has established strategic partnerships with prominent companies, including Toshiba Tec Malaysia and Hitachi Global, to enhance its technology's adoption.

How does VCI Global operate across different sectors?

VCI Global operates in various sectors including Capital Market Consultancy, Fintech, Real Estate, and more, focusing on innovative solutions in each area.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 361

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 232

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 507

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 62

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 223

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 175

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 57

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 233

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Indicators Highlighting Inflation Risks in the US Economy

Updated Category News Views 405

Understanding Inflation Trends and Risks Monitoring inflation trends has become increasingly important in the current economic climate, where the Consumer Price Index (CPI) had previously surged to 9.0%. Now, with inflation levels around 2.7%, many are left observing potential shifts in macroeconomic conditions. As government policies shift, especially with new leadership...

Continue Reading
Cornish Metals Expands Share Capital with New Stock Options

Updated Category News Views 133

Cornish Metals Strengthens Its Financial Position Vancouver-based Cornish Metals Inc. (TSX-V: CUSN, LSE: CUSN) is excited to announce a significant move to bolster its financial stature. The company, known for its focus on mineral exploration and development, specifically its permitted South Crofty tin project, has exercised stock options resulting in the issuance of...

Continue Reading
Jackson Physician Search Celebrates 10 Years of Excellence in Healthcare

Updated Category News Views 149

Jackson Physician Search Celebrated as a Premier Workplace Jackson Physician Search has achieved an impressive milestone by earning No. 2 ranking among medium-sized companies and eighth overall in the esteemed healthcare sector, in the annual Modern Healthcare awards for best places to work. This announcement follows the company's remarkable ten consecutive years on this...

Continue Reading
CAMARA Introduces Revolutionary AI-Driven Network Solutions

Updated Category News Views 128

Revolutionizing AI Applications with CAMARA and MCP CAMARA, an open-source community project, is leading the charge in bridging artificial intelligence (AI) with telecommunication networks via modern APIs. Their innovative approach is outlined in a newly released white paper asserting the capabilities of their Model Context Protocol (MCP) combined with network APIs. The...

Continue Reading
Cohen & Steers Infrastructure Fund: Key Distribution Insights

Updated Category News Views 178

Cohen & Steers Infrastructure Fund Overview Cohen & Steers Infrastructure Fund, Inc. (NASDAQ: UTF) provides valuable investment options focusing on infrastructure. As an influential player in capital assets, the Fund aims to meet the needs of investors looking for sustainable income and growth. Understanding the sources of distribution is essential for shareholders...

Continue Reading